Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-4 of 4 (Search time: 0.003 seconds).
Issue DateTitleAuthor(s)
2014CAN MRI PREDICT PATHOLOGIC RESPONSE OF RECTAL CANCER AFTER NEOADJUVANT TREATMENT?NAHAS, C.; NAHAS, S.; ORTEGA, C.; AZAMBUJA, R.; JOAQUIM, H.; MARQUES, C.; RIBEIRO, U.; BUSTAMANTE, L. L.; HOFF, L. P.; CECCONELLO, I.
2014A Phase I Study of Imatinib, Dacarbazine, and Capecitabine in Advanced Endocrine CancersHALPERIN, Daniel M.; HOFF, Paulo; HOFF, Ana O.; PHAN, Alexandria; YAO, James C.
2014COMPLETE PATHOLOGIC RESPONSE IS ASSOCIATED WITH LESS THAN 12 LYMPH NODES IN THE SPECIMEN OF PATIENTS WITH RECTAL CANCER UNDERGOING NEOADJUVANT THERAPY FOLLOWED BY TOTAL MESORECTAL EXCISIONNAHAS, C.; NAHAS, S.; BUSTAMANTE, L.; MARQUES, C.; COTTI, G.; RIBEIRO JUNIOR, U.; HOFF, P.; CECCONELLO, I.; SALLES, R.; PINTO, R.; IMPERIALE, A.
2015OBSERVATION VERSUS SURGICAL RESECTION IN PATIENTS WITH RECTAL CANCER WHO ACHIEVED COMPLETE CLINICAL RESPONSE AFTER NEOADJUVANT CHEMORADIOTHERAPY: PRELIMINARY RESULTS OF A RANDOMIZED TRIAL (NCT02052921).NAHAS, S.; NAHAS, C.; RIBEIRO JUNIOR, U.; MARQUES, C. Sparapan; COTTI, G. C.; IMPERIALE, A.; ORTEGA, C.; AZAMBUJA, R.; CHEN, A.; HOFF, P.; CECCONELLO, I.
  • previous
  • 1
  • next